Eastman Kodak reporteda 3% decline in revenue last week for its Health Group, whichincludes x-ray film, electronic imaging products and SterlingWinthrop contrast agents, as well as the nonimaging Sterling pharmaceuticalbusiness. X-ray products gained in
Eastman Kodak reporteda 3% decline in revenue last week for its Health Group, whichincludes x-ray film, electronic imaging products and SterlingWinthrop contrast agents, as well as the nonimaging Sterling pharmaceuticalbusiness. X-ray products gained in volume for the period, Kodaksaid. Overall revenues at the film giant were up 1% for the firstquarter (end-March).
Kodak attributed its Health Group's weak performance to theongoing restructuring in U.S. health-care markets. Total HealthGroup revenues dropped to $1.2 billion in the first quarter of1994, from $1.25 in the same period of last year. Revenue in theinternational segment of Kodak's Health Group actually rose 5%,while U.S. revenue was down 9%.
Health Group earnings from operations rose 17% for the quarterfrom $118 million in 1993 to $138 million. This rise in operatingearnings was the lowest of Kodak's three industry segments ofImaging (general photographic), Information and Health. Kodak'stotal worldwide revenue in the first quarter was $3.6 billion.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.